The cyclic nucleotide 3’,5’-cIMP produced by sGC is a second messenger in the vascular wall by unknown
MEETING ABSTRACT Open Access
The cyclic nucleotide 3’,5’-cIMP produced by sGC
is a second messenger in the vascular wall
Paul M Vanhoutte1*, Susan WS Leung1, Yuansheng Gao2
From 7th International Conference on cGMP Generators, Effectors and Therapeutic Implications
Trier, Germany. 19-21 June 2015
Traditionally, only the 3’,5’-cyclic monophosphates of ade-
nosine and guanosine (produced by adenylyl cyclase and
guanylyl cyclases, respectively) are regarded as true ‘second
messengers’ in the vascular wall, despite the presence of
other cyclic nucleotides in different tissues. Among these
non-canonical cyclic nucleotides, inosine 3’,5’-cyclic
monophosphate (cIMP) is synthesized by soluble guanylyl
cyclase in porcine coronary arteries in response to
hypoxia, when the enzyme is activated by endothelium-
derived nitric oxide. Its production is associated with aug-
mentation of vascular contraction mediated by stimulation
of Rho kinase. Similar endothelium-dependent, NO-
dependent and soluble guanylyl cyclase-dependent con-
tractions can be evoked with thymoquinone, which also
augments the levels of cIMP. Based on these findings,
cIMP appears to meet most, if not all, of the criteria
required for it to be accepted as a ‘second messenger’, at
least in the vascular wall. The understanding of the role of
this non-canonical cyclic nucleotide may help identifying
novel therapeutic targets for certain cardiovascular disor-
ders, in particular those associated with sleep apnea.
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